Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Athira Pharma Inc shares valued at $6,083 were sold by San Martin Javier on Jan 02 ’25. At $0.56 per share, San Martin Javier sold 10,826 shares. The insider’s holdings dropped to 35,841 shares worth approximately $11110.71 following the completion of this transaction.
Also, Litton Mark James sold 25,107 shares, netting a total of over 14,108 in proceeds. Following the sale of shares at $0.56 each, the insider now holds 242,591 shares.
Before that, CHURCH KEVIN had sold 8,510 shares from its account. In a trade valued at $4,782, the CHIEF SCIENTIFIC OFFICER traded Athira Pharma Inc shares for $0.56 each. Upon closing the transaction, the insider’s holdings decreased to 8,510 shares, worth approximately $40535.909999999996.
As published in a research note from Mizuho on September 19, 2024, Athira Pharma Inc [ATHA] has been rated down from an Outperform to a Neutral and the price target has been revised to $0.50 from $5. Analysts at Rodman & Renshaw downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early September. As of September 04, 2024, JMP Securities has decreased its “Mkt outperform” rating to a “Mkt perform” for ATHA. Earlier on September 04, 2024, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for ATHA stock which previously was a “a Buy”.
Analyzing ATHA Stock Performance
On last trading session,, Athira Pharma Inc [NASDAQ: ATHA] plunged -3.70% to $0.31. The stock’s lowest price that day was $0.31, but it reached a high of $0.3299 in the same session. During the last five days, there has been a drop of approximately -3.49%. Over the course of the year, Athira Pharma Inc shares have dropped approximately -47.16%. Shares of the company reached a 52-week high of $0.6080 on 01/08/25 and a 52-week low of $0.2195 on 04/08/25.
Support And Resistance Levels for Athira Pharma Inc (ATHA)
According to the 24-hour chart, there is a support level at 0.3034, which, if violated, would cause prices to drop to 0.2967. In the upper region, resistance lies at 0.3233. The next price resistance is at 0.3365. RSI (Relative Strength Index) is 51.36 on the 14-day chart, showing neutral technical sentiment.
Is Athira Pharma Inc subject to short interest?
Stocks of Athira Pharma Inc saw a sharp rise in short interest on 2025-05-30 jumping by 39813.0 shares to 0.89 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.86 million shares. A jump of 4.45% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.69 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.69.
Which companies own the most shares of Athira Pharma Inc (ATHA)?
In terms of Athira Pharma Inc share price expectations, FactSet research, analysts set an average price target of 18 in the next 12 months, up nearly 5525.0% from the previous closing price of $0.32. Analysts anticipate Athira Pharma Inc stock to reach 33 by 2025, with the lowest price target being 3. In spite of this, 2 analysts ranked Athira Pharma Inc stock as Buy at the end of 2025. On August 19, 2024, Rodman & Renshaw assigned a price target of “a Buy” to the stock and initiated coverage with a $22.
